In response to increased competition and evolving needs among healthcare stakeholders, the pharmaceutical industry needs tools to accurately predict launch success.
We looked at the impact eight key performance drivers had on commercial success to better understand outcomes. Our research uncovered how performance drivers evolve across the unmet need spectrum, regardless of therapy area; how entry order affects performance in low unmet need markets (but not others); and how and when novelty does—and does not—drive performance.
During this session, you will explore:
- Winning strategies beyond simply leading with efficacy
- Early choices pharma can make to better drive product success
- Specific examples of how these strategic choices have yielded substantial commercial rewards